[Brentuximab vedotin (cutaneous T-cell lymphoma) - Addendum to Commission G18-01]
Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018003413
German
Original Title:
Brentuximab Vedotin (kutanes T-Zell-Lymphom) - Addendum zum Auftrag G18-01
Details
Project Status:
Completed
URL for project:
https://www.iqwig.de/projekte/g18-06.html
Year Published:
2018
URL for published report:
https://www.iqwig.de/download/G18-06_Brentuximab-Vedotin_Addendum-zum-Auftrag-G18-01_V1-0.pdf
English language abstract:
There is no English language summary available
Publication Type:
Full HTA
Country:
Germany
MeSH Terms
- Lymphoma, T-Cell, Cutaneous
- Antineoplastic Agents, Immunological
- Brentuximab Vedotin
- Antibodies, Monoclonal, Humanized
- Immunotoxins
Keywords
- Brentuximab Vedotin
- Lymphoma - T-Cell - Cutaneous
- Health Care Costs
- Epidemiology
Contact
Organisation Name:
Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address:
IQWiG, Siegburger Str. 237, 50679 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email:
berichte@iqwig.de
Copyright:
Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.